BLMH

gene product
BH
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008]
More gene data

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
28 antibodies from 12 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Novus Biologicals
6 antibodies
Abnova Corporation
4 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
GeneTex
2 antibodies
Aviva Systems Biology
1 antibody
Creative Biomart
3 antibodies
antibodies-online
2 antibodies
LifeSpan BioSciences, Inc.
2 antibodies
Sigma-Aldrich
3 antibodies
Acris Antibodies GmbH
2 antibodies
GenWay
1 antibody